The study was approved by the local IRB (2018-064-02, 29 December 2018), with ClinicalTrails.gov identifier NCT04002596
For more information on our products and services, please don't hesitate to contact us at [email protected]
N., Alnughaythir, A
Growth is the one thing that's, for now at least, missing, at least in comparison to the U.S
EndoC-H1 sublines were maintained in DMEM at 5 mM d-glucose supplemented with 2% BSA, 50 M -mercaptoethanol, 10 mM nicotinamide, 5.5 g ml 1 transferrin, 6.7 ng ml 1 sodium selenite, and 1% penicillin/streptomycin 40
The semaglutide dose had been increased approximately 2 weeks before the surgery, with the last dose given 7 days before surgery